These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [The pathogenetic significance of allergy for blood and bone marrow lesions]. PETRIDES P Ergeb Inn Med Kinderheilkd; 1953; 4():195-256. PubMed ID: 13127841 [No Abstract] [Full Text] [Related]
10. [Non-leukosic leukoblastosis of bone marrow and blood]. LIGOU JC Toulouse Med; 1957 Nov; 58(10):939-71. PubMed ID: 13543844 [No Abstract] [Full Text] [Related]
11. [Classification of tumorous diseases (hemoblastosis) and pre-tumorous conditions of the hematopoietic tissue]. Kraevskiĭ NA; Nemenova NM Arkh Patol; 1971; 33(3):12-6. PubMed ID: 5159538 [No Abstract] [Full Text] [Related]
12. [Cultures of bone marrow cells in semi-solid and liquid media; value in hemopathies (apropos of 4 cases)]. Grégoire MJ; Umana L; Bordigoni P; Chiclet AM; Gilgenkrantz S; Streiff F C R Seances Soc Biol Fil; 1983; 177(3):368-75. PubMed ID: 6225493 [TBL] [Abstract][Full Text] [Related]
13. MRI of the marrow in the paediatric skeleton. Foster K; Chapman S; Johnson K Clin Radiol; 2004 Aug; 59(8):651-73. PubMed ID: 15262540 [TBL] [Abstract][Full Text] [Related]
15. [Blood and bone marrow abnormalities in primary lung cancers (author's transl)]. Piéron R; Constans T; Roland J; Chatelet F Sem Hop; 1980 Jan 18-25; 56(3-4):114-20. PubMed ID: 6244639 [TBL] [Abstract][Full Text] [Related]
17. [Neurologic changes in patients with malignant hemopathies]. Rajić M; Kusić D; Vidaković B; Plećas V Srp Arh Celok Lek; 1983 Feb; 111(2):185-93. PubMed ID: 6670034 [No Abstract] [Full Text] [Related]
18. [Specific inhibitors of the interaction of serum proteins in malignant tumours. Investigation of the frequency of active serum inhibitors and changes of their binding activity]. Suchan M Sb Lek; 1968 Dec; 70(12):360-9. PubMed ID: 5711323 [No Abstract] [Full Text] [Related]